Leave Your Message
ADT1524-Prolgolimab Biosimilar-Anti-PDCD1/PD1/CD279 mAb-Research Grade
Antibody

ADT1524-Prolgolimab Biosimilar-Anti-PDCD1/PD1/CD279 mAb-Research Grade

  • Catalog Number ADT1524
  • Host CHO Cells
  • Species Human
  • Target PDCD1/PD1/CD279
  • Application ELISA, WB

With Alpha Lifetech, you can order biosimilar antibodies when needed. We offer a flexible ordering system that allows you to place orders according to project schedules. Our efficient manufacturing and strict processes ensure timely delivery, ensuring that you can research or produce according to plan.

Products Categories
Featured Products
recommended service
quick links
Contact Us

Product Background

PD-1 is also implicated in the immune response to chronic infections, such as HIV and hepatitis C virus. During chronic infection, PD-1 expression is upregulated on exhausted T cells, leading to impaired immune function. This phenomenon, known as T cell exhaustion, is characterized by reduced cytokine production and proliferative capacity. Targeting the PD-1 pathway in chronic infections has emerged as a potential strategy to restore T cell function.

Product Specification

Catalog Number

ADT1524

Product Name

ADT1524-Prolgolimab Biosimilar-Anti-PDCD1/PD1/CD279 mAb-Research Grade

Alias

BCD-100

Clonity

Monoclonal

Alternate Names

anti-mouse pd-1 antibody,  anti-pd-1 antibody,  anti pd-1 antibody,  recombinant pd-1,  pd-1 antibody,  anti-pd-1 monoclonal antibody,  pd-1 antibodies,  pd-1 recombinant antibody,  pd-1 blocking antibody, CD279 recombinant antibody,  CD279 blocking antibody

Host

CHO Cells

Species

Human

Target

PDCD1/PD-1/CD279

Gene ID

5133

Isotype

IgG1 Kappa Lambda

Size

100ug, 1mg, 5mg

Research Area

Cancer

CAS Number

2093956-19-3

Application

ELISA, WB

Purity

>95% as determined by SDS-PAGE

Concentration

batch dependent

Buffer

Supplied in PBS,  PH7.5

Storage

Store at -20 °C for 12 months. Store at -80 °C for long term storage.

Shipping Condition

Shipped on ice packs.

Note

This product is for research use only.

Reference

1. Ma Y,  et al. Zhonghua Yu Fang Yi Xue Za Zhi,  2023 Jun 6. PMID 37357205
2. Mirsharif ES,  et al. Int Immunopharmacol,  2023 Jun. PMID 37172423
3. Tarique M,  et al. Front Immunol,  2023. PMID 37153623